Both interleukin-23A polymorphism and serum interlukin-23 expression are associated with Graves' disease risk.
Cellular immunology 2015 Mar 294 (1): 39-43.
Jia Huiying, Tao Feng, Liu Changqin, Guo Ting, Zhu Wei, Wang Shu, Cui Bin, Ning Gua
- Page last reviewed:Mar 1, 2018
- Page last updated:Jul 18, 2019
- Content source: